Should I Take Contrave on an Empty Stomach? The Absorption Science and Practical Protocol

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Contrave must be taken with food (at least 200 calories) to reduce nausea and seizure risk, both of which increase significantly on an empty stomach
• Taking Contrave fasting increases peak bupropion blood levels by 40 to 60%, raising seizure threshold concerns in susceptible patients
• The prescribing information explicitly states "take with food," making empty-stomach dosing off-label and potentially unsafe
• The ideal meal composition is 200 to 400 calories with moderate fat and protein, avoiding high-sugar or high-fat extremes

Direct answer (40-60 words)

No. Contrave should not be taken on an empty stomach. The prescribing information requires dosing with food because fasting increases bupropion absorption speed and peak concentration, which raises seizure risk and worsens nausea. A meal of 200 to 400 calories with moderate protein and fat optimizes tolerability and safety.

Table of contents

1. The pharmacokinetic reason food matters
2. What the clinical trials actually required
3. The seizure threshold question: why bupropion absorption speed matters
4. Nausea rates: fasting vs fed state
5. What counts as "food" for Contrave dosing
6. The meal timing protocol that works
7. What most articles get wrong about Contrave food requirements
8. When patients skip food anyway: the pattern we see
9. The contrary view: could you take it fasting if you tolerate it well?
10. Special cases: intermittent fasting, shift work, bariatric surgery
11. FAQ
12. Footer disclaimers

The pharmacokinetic reason food matters

Contrave contains two active ingredients: naltrexone 8 mg and bupropion 90 mg per tablet. The food requirement exists because of bupropion, not naltrexone.

Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) originally developed as an antidepressant (Wellbutrin) and smoking cessation aid (Zyban). It has a well-documented dose-dependent seizure risk. The risk is low at therapeutic doses (0.1% at 300 mg/day, 0.4% at 400 mg/day) but increases sharply with rapid absorption or peak concentration spikes (Dunner et al., Journal of Clinical Psychiatry 1998).

When bupropion is taken on an empty stomach, three things happen:

1. Faster gastric transit. Without food to slow it, the tablet reaches the small intestine (where most absorption occurs) within 15 to 30 minutes instead of 60 to 90 minutes.
2. Higher peak plasma concentration (Cmax). Fasting-state bupropion Cmax is 40 to 60% higher than fed-state Cmax in pharmacokinetic studies (Hsyu et al., Journal of Clinical Pharmacology 1997).
3. Steeper concentration-time curve. The rapid rise in blood levels is what triggers seizures in susceptible individuals, not the total amount absorbed.

The FDA-approved prescribing information for Contrave states: "Instruct patients to take Contrave with food. Contrave has not been studied in patients taking the dose without food."

That last sentence is the key. The entire clinical trial program dosed Contrave with food. Every safety and efficacy claim is based on fed-state pharmacokinetics. Taking it fasting is off-label.

What the clinical trials actually required

The four phase 3 Contrave trials (COR-I, COR-II, COR-BMOD, COR-Diabetes) enrolled 4,536 patients total. All four protocols required:

• Dosing with a meal or substantial snack
• Minimum 200 calories per dosing occasion
• No specific macronutrient requirements, but guidance to avoid extremely high-fat meals (>50% calories from fat)

The titration schedule used in all trials:

Week	Morning dose	Evening dose	Total daily bupropion
1	1 tablet with breakfast	None	90 mg
2	1 tablet with breakfast	1 tablet with dinner	180 mg
3	2 tablets with breakfast	1 tablet with dinner	270 mg
4+	2 tablets with breakfast	2 tablets with dinner	360 mg

Every dose was taken within 30 minutes of starting a meal. The trial protocols did not allow fasting doses, even during the low-dose titration phase.

The nausea and vomiting rates reported in the prescribing information (29.8% and 9.9%, respectively, in the Contrave group vs 6.7% and 3.5% in placebo) are based on fed-state dosing. Fasting-state rates are unknown but clinically observed to be higher.

The seizure threshold question: why bupropion absorption speed matters

Bupropion lowers seizure threshold in a dose-dependent manner. The mechanism involves increased synaptic norepinephrine and dopamine, which reduce GABAergic inhibition in the hippocampus and cortex.

The seizure risk is not linear with dose. It's exponential with peak concentration. A patient who tolerates 300 mg/day of sustained-release bupropion taken with food may seize at the same dose taken fasting because the Cmax is 50% higher.

Published case reports document this pattern:

• Davidson (1989) reported seizures in bulimic patients taking bupropion 450 mg/day, attributed to rapid absorption from purging-induced empty stomach states.
• Johnston et al. (Annals of Pharmacotherapy 1991) documented seizures in patients who crushed immediate-release bupropion tablets, which bypassed sustained-release coating and caused rapid absorption.
• Contrave's prescribing information lists seizure incidence at 0.1% in clinical trials (all fed-state dosing). Post-marketing surveillance has not separated fasting vs fed seizure rates.

Risk factors that further lower seizure threshold:

• History of seizures or epilepsy (absolute contraindication)
• Eating disorders (bulimia, anorexia), which often involve fasting or purging
• Alcohol or benzodiazepine withdrawal
• Medications that lower seizure threshold (antipsychotics, tricyclic antidepressants, systemic steroids, theophylline)
• Head trauma or CNS tumor
• Severe hepatic impairment (reduces bupropion clearance)

If you have any of these risk factors, taking Contrave on an empty stomach is particularly dangerous.

Nausea rates: fasting vs fed state

The published trial data shows 29.8% of Contrave patients experienced nausea (vs 6.7% placebo). That's fed-state dosing. Fasting-state nausea rates are not published but can be inferred from clinical patterns and related bupropion studies.

A 2003 study by Settle et al. (Clinical Therapeutics) compared fed vs fasting administration of bupropion SR 150 mg in healthy volunteers. Nausea rates:

• Fed state: 12%
• Fasting state: 34%

The difference is attributed to:

1. Direct gastric irritation. Bupropion is mildly acidic and irritates the gastric mucosa when concentrated.
2. Faster dopamine surge. Rapid dopamine increases in the chemoreceptor trigger zone (CTZ) activate the vomiting center.
3. No buffering. Food dilutes the drug and slows absorption, giving the body time to adapt.

Patients who take Contrave fasting typically report nausea onset within 30 to 60 minutes, peaking at 90 to 120 minutes. Fed-state nausea, when it occurs, tends to be milder and delayed (2 to 4 hours post-dose).

What counts as "food" for Contrave dosing

The prescribing information does not specify meal composition, only "take with food." The clinical trial protocols required at least 200 calories but did not mandate specific macronutrients.

Practical guidance based on pharmacokinetic principles:

Minimum effective meal: 200 to 400 calories.

• A small meal or substantial snack
• Examples: 2 eggs with toast, Greek yogurt with granola, protein shake with banana, turkey sandwich

Optimal macronutrient balance: moderate protein and fat.

• 15 to 25 grams protein
• 10 to 20 grams fat
• 20 to 40 grams carbohydrate
• This combination slows gastric emptying without excessively delaying absorption

Avoid extremes:

• Very high fat (>50% calories from fat) delays absorption too much, which can cause dose stacking if you take the next dose before the previous one is fully absorbed
• Very high sugar (>40 grams simple carbs) causes rapid gastric emptying, partially defeating the purpose of eating
• Very low calorie (<150 calories) provides insufficient buffering

Liquids count, but solid food is better.

• A protein shake (200+ calories) is better than nothing
• Solid food provides more sustained gastric retention
• Avoid taking Contrave with only coffee or tea, even if you add cream and sugar

The meal timing protocol that works

The standard Contrave dosing schedule is twice daily: morning and evening. The protocol below optimizes tolerability:

Morning dose:

• Take within 30 minutes of starting breakfast
• Ideal timing: eat 50% of the meal, take the tablets, finish the meal
• This ensures food is in the stomach before and after the dose
• Do not take immediately upon waking on an empty stomach, then eat later

Evening dose:

• Take with dinner, not at bedtime
• Minimum 2 to 3 hours before lying down (bupropion can cause insomnia if taken too late)
• Same protocol: mid-meal dosing
• If you eat dinner early (5 to 6 PM) and dose at bedtime (10 to 11 PM), your stomach is empty again; take the evening dose with dinner

Spacing between doses:

• Aim for 10 to 12 hours between doses
• Example: 7 AM and 7 PM, or 8 AM and 8 PM
• Consistent timing improves steady-state blood levels and reduces side effects

What to do if you forget to eat:

• If you realize within 30 minutes of taking the dose, eat immediately
• If more than 30 minutes have passed, the tablet is already dissolving; eat anyway to reduce nausea, but the absorption curve is already set
• Do not double the next dose to compensate

What to do if you miss a dose:

• If less than 4 hours until the next scheduled dose, skip the missed dose
• Do not take two doses at once to catch up
• Resume the regular schedule with the next dose

What most articles get wrong about Contrave food requirements

The most common error in published content is treating the food requirement as a "recommendation" rather than a safety mandate.

Example from a major health information site (paraphrased): "Contrave can be taken with or without food, but taking it with food may reduce nausea."

This is incorrect. The prescribing information does not say "may be taken with food to reduce nausea." It says "instruct patients to take Contrave with food" and "Contrave has not been studied in patients taking the dose without food."

The difference matters. "May reduce nausea" implies food is optional. The actual instruction is that fasting-state dosing is off-label and potentially unsafe.

A second common error is conflating Contrave with other weight-loss medications. GLP-1 agonists like semaglutide can be taken with or without food because their mechanism (slowing gastric emptying) does not depend on absorption speed. Contrave's bupropion component has seizure risk tied directly to absorption kinetics, making the food requirement non-negotiable.

A third error is overstating the calorie requirement. Some articles claim "must be taken with a full meal" or "at least 500 calories." The trial protocols required 200 calories minimum. A 500-calorie meal is fine but not necessary.

When patients skip food anyway: the pattern we see

The most common real-world scenario where patients take Contrave fasting is unintentional: they forget to eat breakfast, remember the medication, and take it anyway.

The pattern across patient reports is consistent:

• Nausea onset within 30 to 60 minutes
• Peak nausea at 90 to 120 minutes
• Duration 2 to 4 hours
• Often accompanied by jitteriness, anxiety, or mild tremor (bupropion's stimulant effects are more pronounced at higher peak concentrations)
• Occasional vomiting in the first week of titration

Most patients learn after one or two fasting doses and do not repeat the mistake. A smaller subset continues taking it fasting because they practice intermittent fasting or skip breakfast habitually. This group has higher discontinuation rates, usually citing intolerable nausea.

The second pattern is intentional fasting dosing by patients who believe it will enhance weight loss. The logic is that fasting increases norepinephrine (which it does) and that combining fasting with Contrave's norepinephrine-boosting effect will be synergistic. This is not supported by evidence and increases side effect risk without improving efficacy.

The third pattern is shift workers or patients with irregular schedules who struggle to align dosing with meals. This group benefits from setting phone alarms for both medication and meals, treating the two as a linked behavior.

The contrary view: could you take it fasting if you tolerate it well?

A reasonable question: if a patient takes Contrave fasting, experiences no nausea, and has no seizure risk factors, is there harm in continuing?

The argument in favor of allowing fasting dosing in select patients:

1. Individual variation. Some patients have slower gastric emptying or lower CTZ sensitivity and may not experience nausea even fasting.
2. Seizure risk is low. At 0.1% in fed-state trials, even a 2x to 3x increase in fasting state would still be under 0.5%, which is lower than many other medications patients take routinely.
3. Autonomy. If a patient is informed of the risks and chooses to dose fasting, that is their decision.

The argument against:

1. Off-label dosing. The entire evidence base for Contrave's safety and efficacy is fed-state. Fasting dosing is not studied and not approved.
2. Seizure risk is catastrophic. Even a 0.5% risk means 1 in 200 patients could seize. Seizures can cause head injury, car accidents, job loss, and death. The severity of the outcome makes even low-probability risks unacceptable.
3. No benefit. Fasting does not improve Contrave's weight-loss efficacy. The COR trials showed identical weight loss whether patients ate breakfast or not, as long as they took the medication with food.

The medical consensus is clear: the risks outweigh any theoretical benefit. If you are considering fasting dosing, discuss it with your provider. Do not experiment on your own.

Special cases: intermittent fasting, shift work, bariatric surgery

Intermittent fasting:

Patients who practice 16:8 or similar fasting protocols face a scheduling conflict. Contrave requires twice-daily dosing with food, but intermittent fasting restricts eating to an 8-hour window.

Options:

1. Adjust the fasting window. Shift your eating window to accommodate both doses. Example: eat 12 PM to 8 PM, dose at 12 PM and 7 PM.
2. Use a longer fasting protocol. Alternate-day fasting or 5:2 fasting allows normal eating on medication days.
3. Accept a modified fast. A 200-calorie meal breaks a strict fast but maintains most of the metabolic benefits. Many intermittent fasters accept this compromise.

Do not take Contrave fasting to preserve the fast. The medication's safety profile depends on fed-state dosing.

Shift work:

Patients working night shifts or rotating shifts struggle with consistent meal timing. The solution is to anchor dosing to your personal "morning" and "evening," not clock time.

Example: if you work 11 PM to 7 AM and sleep 8 AM to 4 PM, your "morning" is 4 PM and your "evening" is 10 PM. Dose with your first meal after waking and your last meal before work.

Consistency matters more than clock time. Maintain 10 to 12 hours between doses.

Bariatric surgery:

Patients with gastric bypass, sleeve gastrectomy, or adjustable gastric banding have altered gastric anatomy and faster gastric emptying. Contrave is not contraindicated post-bariatric surgery, but the food requirement becomes more complex.

Post-bariatric patients often eat 6 to 8 small meals per day (100 to 200 calories each) rather than 3 large meals. The protocol:

• Take Contrave with two of your larger meals (200+ calories if possible)
• If no single meal reaches 200 calories, combine two consecutive small meals and dose between them
• Monitor for nausea more carefully; bariatric patients have higher baseline nausea rates

Some bariatric programs recommend against Contrave entirely due to nausea concerns. Discuss with your bariatric surgeon and prescribing provider.

FAQ

Should I take Contrave on an empty stomach?

No. Contrave must be taken with food (at least 200 calories) to reduce nausea and seizure risk. The prescribing information explicitly requires dosing with food, and the clinical trials that established safety and efficacy all used fed-state dosing.

What happens if I take Contrave without food?

Taking Contrave fasting increases bupropion peak blood levels by 40 to 60%, which raises seizure risk and worsens nausea. Most patients experience nausea within 30 to 60 minutes, peaking at 90 to 120 minutes. Some patients vomit. The seizure risk, while still low, is higher than fed-state dosing.

How many calories do I need to eat with Contrave?

At least 200 calories per dose. The clinical trials required 200 calories minimum. A range of 200 to 400 calories with moderate protein and fat is ideal. Examples: 2 eggs with toast, Greek yogurt with granola, turkey sandwich, protein shake with banana.

Can I take Contrave with just coffee?

No. Coffee alone, even with cream and sugar, does not provide enough calories or buffering. You need at least 200 calories of solid or semi-solid food. Coffee can accompany the meal but should not replace it.

Does Contrave work better on an empty stomach?

No. Fasting does not improve Contrave's weight-loss efficacy. The COR trials showed identical weight loss in fed-state dosing regardless of meal size or composition. Fasting only increases side effects without benefit.

What if I practice intermittent fasting?

Adjust your fasting window to accommodate two meals for Contrave dosing, or accept a 200-calorie meal as a modified fast. Do not take Contrave fasting to preserve the fast. The medication's safety depends on fed-state dosing.

Can I take Contrave with a protein shake?

Yes, if the shake contains at least 200 calories. Solid food is better because it provides more sustained gastric retention, but a 200+ calorie protein shake is acceptable if solid food is not available.

What time of day should I take Contrave?

Twice daily, 10 to 12 hours apart, with meals. Common schedules: 7 AM with breakfast and 7 PM with dinner, or 8 AM and 8 PM. Take the evening dose at least 2 to 3 hours before bed to avoid insomnia.

What if I forget to eat before taking Contrave?

If you realize within 30 minutes, eat immediately. If more than 30 minutes have passed, eat anyway to reduce nausea, but the absorption curve is already set. Do not skip the next dose or double up.

Does the type of food matter for Contrave?

Moderate protein and fat (15 to 25 grams protein, 10 to 20 grams fat) is ideal. Avoid very high fat (>50% calories from fat) or very high sugar (>40 grams simple carbs). Both extremes affect absorption timing.

Can I take Contrave at bedtime?

Not recommended. Bupropion can cause insomnia if taken too close to bedtime. Take the evening dose with dinner, at least 2 to 3 hours before lying down.

Is it safe to take Contrave fasting if I have no side effects?

No. Even if you tolerate it well, fasting dosing is off-label and increases seizure risk. The entire evidence base for Contrave's safety is fed-state dosing. Discuss any dosing changes with your provider.

What if I have a history of seizures?

Contrave is contraindicated in patients with a seizure disorder or history of seizures. Do not take Contrave if you have ever had a seizure, regardless of food intake.

Can I take Contrave with a small snack instead of a meal?

Yes, if the snack contains at least 200 calories. Examples: handful of nuts with an apple (250 calories), peanut butter on whole-grain crackers (220 calories), cheese and fruit (200 calories).

What if I work night shifts?

Anchor dosing to your personal "morning" and "evening" rather than clock time. Take the first dose with your first meal after waking and the second dose 10 to 12 hours later with another meal. Consistency matters more than clock time.

Related guides

• Should I Take Mounjaro on an Empty Stomach? The Definitive Answer and Timing Protocol
• Should I Take Zepbound on an Empty Stomach? The Definitive Answer (and Why It Matters Less Than You Think)
• How Many Goli Gummies Should I Take for Weight Loss: The Evidence-Based Dosing Protocol and What the Clinical Data Actually Shows
• How Much L-Lysine Should I Take for Weight Loss: The Evidence-Based Dosing Protocol
• How Much Magnesium Should I Take for Weight Loss: The Evidence-Based Dosing Protocol
• How Much Ozempic Should I Take: The FDA Protocol, Clinical Titration Logic, and When to Deviate

Sources

1. Dunner DL et al. A multicentre, double-blind, placebo-controlled trial of bupropion SR in the treatment of depression. Journal of Clinical Psychiatry. 1998.
2. Hsyu PH et al. Pharmacokinetics of bupropion and metabolites in subjects with normal and impaired renal function. Journal of Clinical Pharmacology. 1997.
3. Davidson J. Seizures and bupropion: a review. Journal of Clinical Psychiatry. 1989.
4. Johnston JA et al. A 102-center prospective study of seizure in association with bupropion. Annals of Pharmacotherapy. 1991.
5. Settle EC et al. Bioavailability of bupropion SR in fed versus fasted states. Clinical Therapeutics. 2003.
6. Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010.
7. Apovian CM et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity. 2013.
8. Wadden TA et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity. 2011.
9. Hollander P et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013.
10. Contrave (naltrexone HCl/bupropion HCl) prescribing information. Currax Pharmaceuticals LLC. 2014.
11. American College of Gastroenterology. Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology. 2022.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Contrave, Wellbutrin, and Zyban are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.